BioCentury
ARTICLE | Clinical News

Rexahn preclinical data

February 6, 2012 8:00 AM UTC

In vitro, RX-5902 inhibited various human cancer cell lines with IC50 values ranging from of 12-24 nM. Additionally, the small molecule inhibitor of DEAD box polypeptide 5 (DDX5; p68) RNA helicase and...